Amedeo Smart

Free Medical Literature Service

 

Amedeo

Stroke
  Free Subscription

Articles published in
JAMA Neurol
    September 2025
  1. SACHDEV PS, Bentvelzen AC, Kochan NA, Jiang J, et al
    Revised Diagnostic Criteria for Vascular Cognitive Impairment and Dementia-The VasCog-2-WSO Criteria.
    JAMA Neurol. 2025 Sep 16:e253242. doi: 10.1001/jamaneurol.2025.3242.
    >> Share

  2. BARBUTO S, Lee S, Stein J, Kuo SH, et al
    Home Training for Cerebellar Ataxias: A Randomized Clinical Trial.
    JAMA Neurol. 2025 Sep 14:e253421. doi: 10.1001/jamaneurol.2025.3421.
    >> Share

  3. LIU Q, Nie X, Vergouwen MDI, Wang Y, et al
    Gadolinium-Enhanced Aneurysm Wall Imaging and Risk of Intracranial Aneurysm Growth or Rupture.
    JAMA Neurol. 2025 Sep 8:e253209. doi: 10.1001/jamaneurol.2025.3209.
    >> Share

  4. KIMURA T, Sakai S, Ichi S
    Arterial Telescoping Caused by Mechanical Thrombectomy.
    JAMA Neurol. 2025 Sep 2. doi: 10.1001/jamaneurol.2025.3040.
    >> Share

  5. ARTHUR AS, Jahromi BS, Saphier PS, Nickele CM, et al
    Minimally Invasive Surgery vs Medical Management Alone for Intracerebral Hemorrhage: The MIND Randomized Clinical Trial.
    JAMA Neurol. 2025 Sep 2:e253151. doi: 10.1001/jamaneurol.2025.3151.
    >> Share

    August 2025
  6. BARNARD SN, Chen Z, Holmes M, Kanner AM, et al
    Treatment Response to Antiseizure Medications in People With Newly Diagnosed Focal Epilepsy.
    JAMA Neurol. 2025 Aug 25:e252949. doi: 10.1001/jamaneurol.2025.2949.
    >> Share

  7. RINES I, Adeoye O, Barreto AD, Broderick J, et al
    Intravenous Argatroban or Eptifibatide in Patients Undergoing Mechanical Thrombectomy: A Subgroup Analysis of the MOST Randomized Clinical Trial.
    JAMA Neurol. 2025 Aug 18:e252794. doi: 10.1001/jamaneurol.2025.2794.
    >> Share

  8. CHEN H, Lee JS, Yan B, Chaturvedi S, et al
    Reimagining the Treatment of Distal and Medium Vessel Occlusion Strokes.
    JAMA Neurol. 2025 Aug 11. doi: 10.1001/jamaneurol.2025.2628.
    >> Share

  9. ZHOU Y, Zhang L, Cavalcante F, Suzuki K, et al
    Intracranial Hemorrhage in Patients With Stroke After Endovascular Treatment With or Without IV Alteplase: An Individual Participant Data Meta-Analysis.
    JAMA Neurol. 2025 Aug 11:e252610. doi: 10.1001/jamaneurol.2025.2610.
    >> Share

  10. GRUTER T, Gaig C, Crijnen YS, Titulaer MJ, et al
    Early Treatment With Intravenous Immunoglobulins and Outcomes of Patients With Anti-IgLON5 Disease.
    JAMA Neurol. 2025 Aug 4:e252574. doi: 10.1001/jamaneurol.2025.2574.
    >> Share

    July 2025
  11. HAN Y, Liu Z
    Unusual Finding of Filling Defect During Mechanical Thrombectomy.
    JAMA Neurol. 2025 Jul 21. doi: 10.1001/jamaneurol.2025.2227.
    >> Share

  12. HOU X, Huang J, Wang L, He Y, et al
    Intra-Arterial Tenecteplase After Successful Reperfusion in Large Vessel Occlusion Stroke: A Randomized Clinical Trial.
    JAMA Neurol. 2025 Jul 5:e252036. doi: 10.1001/jamaneurol.2025.2036.
    >> Share

    June 2025
  13. CLOCCHIATTI-TUOZZO S, Rivier CA, Renedo D, Huo S, et al
    APOE epsilon4 and Risk of Intracranial Hemorrhage in Patients With Atrial Fibrillation Taking Apixaban.
    JAMA Neurol. 2025 Jun 23:e250182. doi: 10.1001/jamaneurol.2025.0182.
    >> Share

  14. CHASSE M, Shankar JJS, Fergusson DA, English SW, et al
    Computed Tomography Perfusion and Angiography for Death by Neurologic Criteria.
    JAMA Neurol. 2025 Jun 13:e252375. doi: 10.1001/jamaneurol.2025.2375.
    >> Share

  15. ALEXANDROV AW, Shearin AJ, Mandava P, Torrealba-Acosta G, et al
    Optimal Head-of-Bed Positioning Before Thrombectomy in Large Vessel Occlusion Stroke: A Randomized Clinical Trial.
    JAMA Neurol. 2025 Jun 4:e252253. doi: 10.1001/jamaneurol.2025.2253.
    >> Share

  16. SMITH JR, Pike JR, Gottesman RF, Knopman DS, et al
    Contribution of Modifiable Midlife and Late-Life Vascular Risk Factors to Incident Dementia.
    JAMA Neurol. 2025 Jun 2:e251495. doi: 10.1001/jamaneurol.2025.1495.
    >> Share

    May 2025
  17. RAUTALIN I, Volovici V, Stark BA, Johnson CO, et al
    Global, Regional, and National Burden of Nontraumatic Subarachnoid Hemorrhage: The Global Burden of Disease Study 2021.
    JAMA Neurol. 2025 May 23. doi: 10.1001/jamaneurol.2025.1522.
    >> Share

  18. MCCABE JJ, Cheung Y, Foley M, Brennan SO, et al
    Residual Risk of Recurrent Stroke Despite Anticoagulation in Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis.
    JAMA Neurol. 2025 May 21:e251337. doi: 10.1001/jamaneurol.2025.1337.
    >> Share

  19. PACZYNSKI M, Hofmann A, Posey Z, Gregersen M, et al
    Lecanemab Treatment in a Specialty Memory Clinic.
    JAMA Neurol. 2025 May 12:e251232. doi: 10.1001/jamaneurol.2025.1232.
    >> Share

  20. OLTHUIS SGH, Pinckaers FME, Robbe MMQ, de Ridder IR, et al
    CT Perfusion Imaging After Selection for Late-Window Endovascular Stroke Treatment: Secondary Analysis of the MR CLEAN-LATE Randomized Trial.
    JAMA Neurol. 2025 May 5:e250716. doi: 10.1001/jamaneurol.2025.0716.
    >> Share

    April 2025
  21. BUTCHER KS, Buck B, Dowlatshahi D, Gioia LC, et al
    Acute Blood Pressure Lowering and Risk of Ischemic Lesions on MRI After Intracerebral Hemorrhage.
    JAMA Neurol. 2025 Apr 21:e250586. doi: 10.1001/jamaneurol.2025.0586.
    >> Share

  22. ZAWAR I, Quigg M, Johnson EL, Ghosal S, et al
    Risk Factors Associated With Late-Onset Epilepsy in Dementia and Mild Cognitive Impairment.
    JAMA Neurol. 2025 Apr 14:e250552. doi: 10.1001/jamaneurol.2025.0552.
    >> Share

  23. VERBURGT E, Fellah L, Ekker MS, Schellekens MMI, et al
    Risk of Poststroke Epilepsy Among Young Adults With Ischemic Stroke or Intracerebral Hemorrhage.
    JAMA Neurol. 2025 Apr 14:e250465. doi: 10.1001/jamaneurol.2025.0465.
    >> Share

  24. YANG M, Sun H, Li L, Wu Q, et al
    Use of a Robot-Assisted Thrombectomy System in Acute Ischemic Stroke.
    JAMA Neurol. 2025 Apr 7:e250418. doi: 10.1001/jamaneurol.2025.0418.
    >> Share

    March 2025
  25. WARACH SJ, Davis LA, Lawrence P, Gajewski B, et al
    Optimal Delay Time to Initiate Anticoagulation After Ischemic Stroke in Atrial Fibrillation: A Pragmatic, Response-Adaptive Randomized Clinical Trial.
    JAMA Neurol. 2025 Mar 31:e250285. doi: 10.1001/jamaneurol.2025.0285.
    >> Share

  26. BOERSMA LVA, Werring DJ, Seiffge DJ
    Immortal Time Bias and Nonlinear Stroke Recurrence Risk-Reply.
    JAMA Neurol. 2025 Mar 31. doi: 10.1001/jamaneurol.2025.0392.
    >> Share

  27. SHEFNER JM, Cudkowicz ME, Genge A, Hardiman O, et al
    Reldesemtiv in Amyotrophic Lateral Sclerosis: Results From the COURAGE-ALS Randomized Clinical Trial.
    JAMA Neurol. 2025 Mar 24:e250241. doi: 10.1001/jamaneurol.2025.0241.
    >> Share

  28. VAILLANCOURT DE, Barmpoutis A, Wu SS, DeSimone JC, et al
    Automated Imaging Differentiation for Parkinsonism.
    JAMA Neurol. 2025 Mar 17:e250112. doi: 10.1001/jamaneurol.2025.0112.
    >> Share

  29. GOELDLIN MB, Fandler-Hofler S, Pezzini A, Manikantan A, et al
    Location and Timing of Recurrent, Nontraumatic Intracerebral Hemorrhage.
    JAMA Neurol. 2025 Mar 3:e250026. doi: 10.1001/jamaneurol.2025.0026.
    >> Share

    February 2025
  30. RIPART M, Spitzer H, Williams LZJ, Walger L, et al
    Detection of Epileptogenic Focal Cortical Dysplasia Using Graph Neural Networks: A MELD Study.
    JAMA Neurol. 2025 Feb 24:e245406. doi: 10.1001/jamaneurol.2024.5406.
    >> Share

  31. YUN J, Shin D, Lee EH, Kim JP, et al
    Temporal Dynamics and Biological Variability of Alzheimer Biomarkers.
    JAMA Neurol. 2025 Feb 17:e245263. doi: 10.1001/jamaneurol.2024.5263.
    >> Share

  32. ANDREWS J, Paganoni S, Macklin EA, Chibnik LB, et al
    Verdiperstat in Amyotrophic Lateral Sclerosis: Results From the Randomized HEALEY ALS Platform Trial.
    JAMA Neurol. 2025 Feb 17:e245249. doi: 10.1001/jamaneurol.2024.5249.
    >> Share

  33. DEL BENE VA, Howard G, Gropen TI, Lyerly MJ, et al
    Cognitive Decline After First-Time Transient Ischemic Attack.
    JAMA Neurol. 2025 Feb 10:e245082. doi: 10.1001/jamaneurol.2024.5082.
    >> Share

  34. VANDEVREDE L, Cho H, Sanderson-Cimino M, Wekselman F, et al
    Detection of Alzheimer Neuropathology in Alzheimer and Non-Alzheimer Clinical Syndromes With Blood-Based Biomarkers.
    JAMA Neurol. 2025 Feb 10:e245017. doi: 10.1001/jamaneurol.2024.5017.
    >> Share

  35. HILDERLEY AJ, Dunbar M, Andersen J, Fehlings D, et al
    Neuromodulation for Children With Hemiparesis and Perinatal Stroke: A Randomized Clinical Trial.
    JAMA Neurol. 2025 Feb 3:e244898. doi: 10.1001/jamaneurol.2024.4898.
    >> Share

  36. LAU WK, Fehnel CR, Macchi ZA, Mehta AK, et al
    Research Priorities in Neuropalliative Care: A Consensus Statement From the International Neuropalliative Care Society.
    JAMA Neurol. 2025 Feb 3. doi: 10.1001/jamaneurol.2024.4932.
    >> Share

  37. BOUILLE F, De Malherbe M, Pico F
    Ischemic Stroke Due to Compression of a Wandering Internal Carotid Artery by the Hyoid Bone.
    JAMA Neurol. 2025 Feb 3. doi: 10.1001/jamaneurol.2024.5028.
    >> Share

    January 2025
  38. LANSBERG MG, Wintermark M, Chen H, Howard G, et al
    Apixaban to Prevent Covert Infarcts After Cryptogenic Stroke in Patients With Atrial Cardiopathy: A Secondary Analysis of the ARCADIA Randomized Clinical Trial.
    JAMA Neurol. 2025 Jan 27:e244838. doi: 10.1001/jamaneurol.2024.4838.
    >> Share

  39. XIONG Y, Meng X, Jin A, Campbell BCV, et al
    Prourokinase vs Standard Care for Patients With Mild Ischemic Stroke: The PUMICE Randomized Clinical Trial.
    JAMA Neurol. 2025 Jan 21. doi: 10.1001/jamaneurol.2024.4688.
    >> Share

  40. ZHU J, Kim KR, Yu H, Gupta A, et al
    Acute Ischemic Stroke Care Quality Improvement.
    JAMA Neurol. 2025 Jan 13. doi: 10.1001/jamaneurol.2024.4604.
    >> Share

  41. YANG S, Orlova Y, Park H, Smith SM, et al
    Cardiovascular Safety of Anti-CGRP Monoclonal Antibodies in Older Adults or Adults With Disability With Migraine.
    JAMA Neurol. 2025 Jan 6. doi: 10.1001/jamaneurol.2024.4537.
    >> Share

    December 2024
  42. HANSEN D, den Hartog SJ, van Leeuwen N, Boiten J, et al
    Quality Improvement Intervention for Reducing Acute Treatment Times in Ischemic Stroke: A Cluster Randomized Clinical Trial.
    JAMA Neurol. 2024 Dec 16. doi: 10.1001/jamaneurol.2024.4304.
    >> Share

    November 2024
  43. GRAVESTEIJN G, Rutten JW, Cerfontaine MN, Hack RJ, et al
    Disease Severity Staging System for NOTCH3-Associated Small Vessel Disease, Including CADASIL.
    JAMA Neurol. 2024 Nov 29. doi: 10.1001/jamaneurol.2024.4487.
    >> Share

  44. MEADOR KJ, Cohen MJ, Loring DW, Matthews AG, et al
    Neuropsychological Outcomes in 6-Year-Old Children of Women With Epilepsy: A Prospective Nonrandomized Clinical Trial.
    JAMA Neurol. 2024 Nov 25:e243982. doi: 10.1001/jamaneurol.2024.3982.
    >> Share

  45. KWON CS, Rafati A, Ottman R, Christensen J, et al
    Psychiatric Comorbidities in Persons With Epilepsy Compared With Persons Without Epilepsy: A Systematic Review and Meta-Analysis.
    JAMA Neurol. 2024 Nov 25:e243976. doi: 10.1001/jamaneurol.2024.3976.
    >> Share

  46. TSAI CC, Hu C, Ding J, Bui E, et al
    Trends in Gender, Racial, and Ethnic Representation Among US Neurology Faculty.
    JAMA Neurol. 2024 Nov 18:e243909. doi: 10.1001/jamaneurol.2024.3909.
    >> Share

  47. AYTON S, Barton D, Brew B, Brodtmann A, et al
    Deferiprone in Alzheimer Disease: A Randomized Clinical Trial.
    JAMA Neurol. 2024 Nov 4:e243733. doi: 10.1001/jamaneurol.2024.3733.
    >> Share

  48. LI J, Shlobin NA, Thijs RD, Sylvestre MP, et al
    Antiseizure Medications and Cardiovascular Events in Older People With Epilepsy in the Canadian Longitudinal Study on Aging.
    JAMA Neurol. 2024;81:1178-1186.
    >> Share

    October 2024
  49. MAC GRORY B, Sun JL, Alhanti B, Lusk J, et al
    Mobile Stroke Unit Management in Patients With Acute Ischemic Stroke Eligible for Intravenous Thrombolysis.
    JAMA Neurol. 2024 Oct 28. doi: 10.1001/jamaneurol.2024.3659.
    >> Share

  50. NAVI BB, Khatri P
    Mobile Stroke Units-Time for Legislation and Renumeration.
    JAMA Neurol. 2024 Oct 28. doi: 10.1001/jamaneurol.2024.3627.
    >> Share

  51. LINDGREN E, Shu L, Simaan N, Krzywicka K, et al
    Development and Validation of a Clinical Score to Predict Epilepsy After Cerebral Venous Thrombosis.
    JAMA Neurol. 2024 Oct 21. doi: 10.1001/jamaneurol.2024.3481.
    >> Share

  52. KHAN F, Hill MD
    Sex Differences in Case-Fatality Rates of Stroke.
    JAMA Neurol. 2024;81:1102-1103.
    >> Share

    September 2024
  53. LI J, Shlobin NA, Thijs RD, Sylvestre MP, et al
    Antiseizure Medications and Cardiovascular Events in Older People With Epilepsy.
    JAMA Neurol. 2024 Sep 30. doi: 10.1001/jamaneurol.2024.3210.
    >> Share

  54. MAARSE M, Seiffge DJ, Werring DJ, Boersma LVA, et al
    Left Atrial Appendage Occlusion vs Standard of Care After Ischemic Stroke Despite Anticoagulation.
    JAMA Neurol. 2024 Sep 23:e242882. doi: 10.1001/jamaneurol.2024.2882.
    >> Share

    August 2024
  55. LI R, Tao C, Sun J, Zhang C, et al
    Endovascular vs Medical Management of Acute Basilar Artery Occlusion: A Secondary Analysis of a Randomized Clinical Trial.
    JAMA Neurol. 2024 Aug 26:e242652. doi: 10.1001/jamaneurol.2024.2652.
    >> Share

  56. RENEDO D, Sheth KN
    Sex Differences in Case-Fatality Rates of Stroke-Reply.
    JAMA Neurol. 2024 Aug 19. doi: 10.1001/jamaneurol.2024.2599.
    >> Share

  57. WESSELS L, Wolf S, Adage T, Breitenbach J, et al
    Localized Nicardipine Release Implants for Prevention of Vasospasm After Aneurysmal Subarachnoid Hemorrhage: A Randomized Clinical Trial.
    JAMA Neurol. 2024 Aug 19:e242564. doi: 10.1001/jamaneurol.2024.2564.
    >> Share

  58. NAVI BB, Zhang C, Miller B, Cushman M, et al
    Apixaban vs Aspirin in Patients With Cancer and Cryptogenic Stroke: A Post Hoc Analysis of the ARCADIA Randomized Clinical Trial.
    JAMA Neurol. 2024 Aug 12:e242404. doi: 10.1001/jamaneurol.2024.2404.
    >> Share

  59. CHEN H, Lee JS, Michel P, Yan B, et al
    Endovascular Stroke Thrombectomy for Patients With Large Ischemic Core: A Review.
    JAMA Neurol. 2024 Aug 12. doi: 10.1001/jamaneurol.2024.2500.
    >> Share

    July 2024
  60. HADAD R, Mandelli ML, Rankin KP, Toohey C, et al
    Itching Frequency and Neuroanatomic Correlates in Frontotemporal Lobar Degeneration.
    JAMA Neurol. 2024 Jul 22:e242213. doi: 10.1001/jamaneurol.2024.2213.
    >> Share

  61. ASKEN BM, Scholz SW, Prokop S
    Substantia(l) Impacts of Contact Sport Play and Parkinsonism.
    JAMA Neurol. 2024 Jul 15. doi: 10.1001/jamaneurol.2024.2162.
    >> Share

  62. COLUMBO JA, Daya N, Colantonio LD, Wang Z, et al
    Derivation and Validation of ICD-10 Codes for Identifying Incident Stroke.
    JAMA Neurol. 2024 Jul 1:e242044. doi: 10.1001/jamaneurol.2024.2044.
    >> Share

  63. PRABHAKARAN S, Romano JG
    Symptomatic Hemorrhage Risks in Stroke Thrombolysis: aDAPTing to Real-World Practice.
    JAMA Neurol. 2024;81:689-691.
    >> Share

    June 2024
  64. HINDSHOLM MF, Garcia Rodriguez LA, Brandes A, Hallas J, et al
    Recurrent Ischemic Stroke in Patients With Atrial Fibrillation While Receiving Oral Anticoagulants.
    JAMA Neurol. 2024 Jun 24:e241892. doi: 10.1001/jamaneurol.2024.1892.
    >> Share

  65. BAX F, Greenberg SM
    Cerebral Amyloid Angiopathy and Nontraumatic Subdural Hemorrhage.
    JAMA Neurol. 2024 Jun 10. doi: 10.1001/jamaneurol.2024.1595.
    >> Share

  66. SEITZ A, Merkler AE
    Time to Think About Myocardial Infarction in Acute Ischemic Stroke.
    JAMA Neurol. 2024 Jun 3. doi: 10.1001/jamaneurol.2024.1547.
    >> Share

  67. JOUNDI RA, Smith EE, Ganesh A, Nogueira RG, et al
    Time From Hospital Arrival Until Endovascular Thrombectomy and Patient-Reported Outcomes in Acute Ischemic Stroke.
    JAMA Neurol. 2024 Jun 3:e241562. doi: 10.1001/jamaneurol.2024.1562.
    >> Share

  68. NOLTE CH, von Rennenberg R, Litmeier S, Leistner DM, et al
    Type 1 Myocardial Infarction in Patients With Acute Ischemic Stroke.
    JAMA Neurol. 2024 Jun 3:e241552. doi: 10.1001/jamaneurol.2024.1552.
    >> Share

    May 2024
  69. GAO Y, Jiang L, Pan Y, Chen W, et al
    Immediate- or Delayed-Intensive Statin in Acute Cerebral Ischemia: The INSPIRES Randomized Clinical Trial.
    JAMA Neurol. 2024 May 28:e241433. doi: 10.1001/jamaneurol.2024.1433.
    >> Share

  70. GOELDLIN MB, Hakim A, Branca M, Abend S, et al
    Early vs Late Anticoagulation in Minor, Moderate, and Major Ischemic Stroke With Atrial Fibrillation: Post Hoc Analysis of the ELAN Randomized Clinical Trial.
    JAMA Neurol. 2024 May 28:e241450. doi: 10.1001/jamaneurol.2024.1450.
    >> Share

  71. LI Y, Ren T, Burgess M, Chen Z, et al
    Early Access to First-Seizure Clinics, Subsequent Outcomes, and Factors Associated With Attendance.
    JAMA Neurol. 2024 May 23:e241187. doi: 10.1001/jamaneurol.2024.1187.
    >> Share

  72. PENG TJ, Schwamm LH, Fonarow GC, Hassan AE, et al
    Contemporary Prestroke Dual Antiplatelet Use and Symptomatic Intracerebral Hemorrhage Risk After Thrombolysis.
    JAMA Neurol. 2024 May 20:e241312. doi: 10.1001/jamaneurol.2024.1312.
    >> Share

  73. KAUFMANN JE, Harshfield EL, Gensicke H, Wegener S, et al
    Antithrombotic Treatment for Cervical Artery Dissection: A Systematic Review and Individual Patient Data Meta-Analysis.
    JAMA Neurol. 2024 May 13:e241141. doi: 10.1001/jamaneurol.2024.1141.
    >> Share

    April 2024
  74. ZHAO W, Li S, Li C, Wu C, et al
    Effects of Tirofiban on Neurological Deterioration in Patients With Acute Ischemic Stroke: A Randomized Clinical Trial.
    JAMA Neurol. 2024 Apr 22:e240868. doi: 10.1001/jamaneurol.2024.0868.
    >> Share

  75. KOURI N, Frankenhauser I, Peng Z, Labuzan SA, et al
    Clinicopathologic Heterogeneity and Glial Activation Patterns in Alzheimer Disease.
    JAMA Neurol. 2024 Apr 15:e240784. doi: 10.1001/jamaneurol.2024.0784.
    >> Share

  76. PEASE M, Mittal A, Merkaj S, Okonkwo DO, et al
    Early Seizure Prophylaxis in Mild and Moderate Traumatic Brain Injury: A Systematic Review and Meta-Analysis.
    JAMA Neurol. 2024 Apr 8:e240689. doi: 10.1001/jamaneurol.2024.0689.
    >> Share

  77. HABIB S, Butt H, Goldenholz SR, Chang CY, et al
    Large Language Model Performance on Practice Epilepsy Board Examinations.
    JAMA Neurol. 2024 Apr 8:e240676. doi: 10.1001/jamaneurol.2024.0676.
    >> Share

  78. SPOTNITZ M, Ekanayake CD, Ostropolets A, McKhann GM, et al
    Use of Recommended Neurodiagnostic Evaluation Among Patients With Drug-Resistant Epilepsy.
    JAMA Neurol. 2024 Apr 1:e240551. doi: 10.1001/jamaneurol.2024.0551.
    >> Share

    March 2024
  79. DECARLI C, Maillard P, Pase MP, Beiser AS, et al
    Trends in Intracranial and Cerebral Volumes of Framingham Heart Study Participants Born 1930 to 1970.
    JAMA Neurol. 2024 Mar 25:e240469. doi: 10.1001/jamaneurol.2024.0469.
    >> Share

  80. CHEN HS, Cui Y, Wang XH, Ma YT, et al
    Clopidogrel Plus Aspirin vs Aspirin Alone in Patients With Acute Mild to Moderate Stroke: The ATAMIS Randomized Clinical Trial.
    JAMA Neurol. 2024 Mar 11:e240146. doi: 10.1001/jamaneurol.2024.0146.
    >> Share

  81. CHENG A, Xue J, Wang A, Xu Q, et al
    LDL-C Levels and Bleeding Risk in Patients Taking DAPT After Minor Ischemic Stroke or TIA.
    JAMA Neurol. 2024 Mar 4:e240086. doi: 10.1001/jamaneurol.2024.0086.
    >> Share

  82. RENEDO D, Acosta JN, Leasure AC, Sharma R, et al
    Burden of Ischemic and Hemorrhagic Stroke Across the US From 1990 to 2019.
    JAMA Neurol. 2024 Mar 4:e240190. doi: 10.1001/jamaneurol.2024.0190.
    >> Share

    February 2024
  83. WON SY, Hernandez-Duran S, Behmanesh B, Bernstock JD, et al
    Functional Outcomes in Conservatively vs Surgically Treated Cerebellar Infarcts.
    JAMA Neurol. 2024 Feb 26:e235773. doi: 10.1001/jamaneurol.2023.5773.
    >> Share

  84. SCHNEIDER ALC, Law CA, Gottesman RF, Krauss G, et al
    Posttraumatic Epilepsy and Dementia Risk.
    JAMA Neurol. 2024 Feb 26:e240010. doi: 10.1001/jamaneurol.2024.0010.
    >> Share

  85. ANDERSON CS, Song L
    Promising Efforts to Define a Novel Approach to Neuroprotection for Acute Ischemic Stroke.
    JAMA Neurol. 2024 Feb 19. doi: 10.1001/jamaneurol.2023.5727.
    >> Share

  86. FU Y, Wang A, Tang R, Li S, et al
    Sublingual Edaravone Dexborneol for the Treatment of Acute Ischemic Stroke: The TASTE-SL Randomized Clinical Trial.
    JAMA Neurol. 2024 Feb 19:e235716. doi: 10.1001/jamaneurol.2023.5716.
    >> Share

  87. MUTLU U, Fokkink WJR, van Kooten F
    Shifting Carotid Web Due to a Wandering and Rotating Carotid Artery.
    JAMA Neurol. 2024 Feb 12. doi: 10.1001/jamaneurol.2023.5641.
    >> Share

  88. SHETH KN, Solomon N, Alhanti B, Messe SR, et al
    Time to Anticoagulation Reversal and Outcomes After Intracerebral Hemorrhage.
    JAMA Neurol. 2024 Feb 9. doi: 10.1001/jamaneurol.2024.0221.
    >> Share

  89. SARRAJ A, Hill MD, Hussain MS, Abraham MG, et al
    Endovascular Thrombectomy Treatment Effect in Direct vs Transferred Patients With Large Ischemic Strokes: A Prespecified Analysis of the SELECT2 Trial.
    JAMA Neurol. 2024 Feb 8. doi: 10.1001/jamaneurol.2024.0206.
    >> Share

  90. MEINEL TR, Wardlaw JM, Kent DM
    Is Incidentally Discovered Covert Cerebrovascular Disease Ignorable?
    JAMA Neurol. 2024 Feb 5. doi: 10.1001/jamaneurol.2023.5456.
    >> Share

  91. PETERSEN CL, Hougaard A, Gaist D, Hallas J, et al
    Risk of Stroke and Myocardial Infarction Among Initiators of Triptans.
    JAMA Neurol. 2024 Feb 5. doi: 10.1001/jamaneurol.2023.5549.
    >> Share

  92. CUCCHIARA B, Majersik JJ
    The Case of Anticoagulation for Progressing Stroke: Have We Come Full Circle?
    JAMA Neurol. 2024;81:113-114.
    >> Share

    January 2024
  93. DE HAVENON A, Zhou LW, Koo AB, Matouk C, et al
    Endovascular Treatment of Acute Ischemic Stroke After Cardiac Interventions in the United States.
    JAMA Neurol. 2024 Jan 29. doi: 10.1001/jamaneurol.2023.5416.
    >> Share

  94. HOUKIN K, Osanai T, Uchiyama S, Minematsu K, et al
    Allogeneic Stem Cell Therapy for Acute Ischemic Stroke: The Phase 2/3 TREASURE Randomized Clinical Trial.
    JAMA Neurol. 2024 Jan 16:e235200. doi: 10.1001/jamaneurol.2023.5200.
    >> Share

  95. ZHANG X, Zhong W, Xue R, Jin H, et al
    Argatroban in Patients With Acute Ischemic Stroke With Early Neurological Deterioration: A Randomized Clinical Trial.
    JAMA Neurol. 2024 Jan 8:e235093. doi: 10.1001/jamaneurol.2023.5093.
    >> Share

  96. NOGUEIRA RG, Lobsien D, Klisch J, Pielenz D, et al
    Thrombectomy With the pRESET vs Solitaire Stent Retrievers as First-Line Large Vessel Occlusion Stroke Treatment: A Randomized Clinical Trial.
    JAMA Neurol. 2024 Jan 2:e235010. doi: 10.1001/jamaneurol.2023.5010.
    >> Share

    December 2023
  97. RIVIER CA, Kamel H, Sheth KN, Iadecola C, et al
    Cerebral Amyloid Angiopathy and Risk of Isolated Nontraumatic Subdural Hemorrhage.
    JAMA Neurol. 2023 Dec 26:e234918. doi: 10.1001/jamaneurol.2023.4918.
    >> Share

  98. HENDRIKS S, Ranson JM, Peetoom K, Lourida I, et al
    Risk Factors for Young-Onset Dementia in the UK Biobank.
    JAMA Neurol. 2023 Dec 26:e234929. doi: 10.1001/jamaneurol.2023.4929.
    >> Share

  99. BUCK BH, Sposato LA, Field TS
    Looking for Atrial Fibrillation With Insertable Cardiac Monitors-Is 1 Year Long Enough and Does it Matter?
    JAMA Neurol. 2023;80:1266-1268.
    >> Share

  100. BRAKSICK SA, Rabinstein AA
    Antiplatelets Are Enough for Nondisabling Strokes.
    JAMA Neurol. 2023;80:1263-1264.
    >> Share

    November 2023
  101. IAFFALDANO P, Portaccio E, Lucisano G, Simone M, et al
    Multiple Sclerosis Progression and Relapse Activity in Children.
    JAMA Neurol. 2023 Nov 27:e234455. doi: 10.1001/jamaneurol.2023.4455.
    >> Share

  102. HUA L, Zhao Y, Han YS
    A Young Woman With Hypertonia, Severe Scoliosis, and Encephalopathy.
    JAMA Neurol. 2023 Nov 27. doi: 10.1001/jamaneurol.2023.4245.
    >> Share

  103. SUN D, Guo X, Nguyen TN, Pan Y, et al
    Alberta Stroke Program Early Computed Tomography Score, Infarct Core Volume, and Endovascular Therapy Outcomes in Patients With Large Infarct: A Secondary Analysis of the ANGEL-ASPECT Trial.
    JAMA Neurol. 2023 Nov 27:e234430. doi: 10.1001/jamaneurol.2023.4430.
    >> Share

  104. COHEN MJ, Meador KJ, Loring DW, Matthews AG, et al
    Behavioral Outcomes and Neurodevelopmental Disorders Among Children of Women With Epilepsy.
    JAMA Neurol. 2023 Nov 20:e234315. doi: 10.1001/jamaneurol.2023.4315.
    >> Share

  105. STEWARD A, Biel D, Dewenter A, Roemer S, et al
    ApoE4 and Connectivity-Mediated Spreading of Tau Pathology at Lower Amyloid Levels.
    JAMA Neurol. 2023 Nov 6:e234038. doi: 10.1001/jamaneurol.2023.4038.
    >> Share

  106. ABDELHAK A, Benkert P, Schaedelin S, Boscardin WJ, et al
    Neurofilament Light Chain Elevation and Disability Progression in Multiple Sclerosis.
    JAMA Neurol. 2023 Nov 6:e233997. doi: 10.1001/jamaneurol.2023.3997.
    >> Share

  107. ZACHRISON KS, Beaulieu ND, Mehrotra A
    Changing Health Care Markets Have the Potential to Undermine Stroke Systems of Care.
    JAMA Neurol. 2023;80:1131-1132.
    >> Share

    October 2023
  108. BERNSTEIN RA, Kamel H, Granger CB, Piccini JP, et al
    Atrial Fibrillation In Patients With Stroke Attributed to Large- or Small-Vessel Disease: 3-Year Results From the STROKE AF Randomized Clinical Trial.
    JAMA Neurol. 2023 Oct 30:e233931. doi: 10.1001/jamaneurol.2023.3931.
    >> Share

  109. SMITH AG, Singleton JR, Aperghis A, Coffey CS, et al
    Safety and Efficacy of Topiramate in Individuals With Cryptogenic Sensory Peripheral Neuropathy With Metabolic Syndrome: The TopCSPN Randomized Clinical Trial.
    JAMA Neurol. 2023 Oct 23:e233711. doi: 10.1001/jamaneurol.2023.3711.
    >> Share

  110. LAVALLEE PC, Charles H, Albers GW, Caplan LR, et al
    Underlying Causes of TIA and Minor Ischemic Stroke and Risk of Major Vascular Events.
    JAMA Neurol. 2023 Oct 2:e233344. doi: 10.1001/jamaneurol.2023.3344.
    >> Share

    September 2023
  111. MARTINEZ-GUTIERREZ JC, Kim Y, Salazar-Marioni S, Tariq MB, et al
    Automated Large Vessel Occlusion Detection Software and Thrombectomy Treatment Times: A Cluster Randomized Clinical Trial.
    JAMA Neurol. 2023 Sep 18:e233206. doi: 10.1001/jamaneurol.2023.3206.
    >> Share

  112. MISRA S, Kasner SE, Dawson J, Tanaka T, et al
    Outcomes in Patients With Poststroke Seizures: A Systematic Review and Meta-Analysis.
    JAMA Neurol. 2023 Sep 18:e233240. doi: 10.1001/jamaneurol.2023.3240.
    >> Share

  113. ELSER H, Vijayaraghavan M, Kasner SE
    E-Cigarettes and Stroke Risk-Present Uncertainties and Future Directions.
    JAMA Neurol. 2023;80:883-884.
    >> Share

    August 2023
  114. MCKEE AC, Mez J, Abdolmohammadi B, Butler M, et al
    Neuropathologic and Clinical Findings in Young Contact Sport Athletes Exposed to Repetitive Head Impacts.
    JAMA Neurol. 2023 Aug 28:e232907. doi: 10.1001/jamaneurol.2023.2907.
    >> Share

  115. WECHSLER PM, Navi BB
    Bypassing Closest Stroke Center for Intracerebral Hemorrhage-Not So Fast!
    JAMA Neurol. 2023 Aug 21. doi: 10.1001/jamaneurol.2023.2753.
    >> Share

  116. RAMOS-PACHON A, Rodriguez-Luna D, Marti-Fabregas J, Millan M, et al
    Effect of Bypassing the Closest Stroke Center in Patients with Intracerebral Hemorrhage: A Secondary Analysis of the RACECAT Randomized Clinical Trial.
    JAMA Neurol. 2023 Aug 21:e232754. doi: 10.1001/jamaneurol.2023.2754.
    >> Share

  117. HAUSER RA, Espay AJ, Ellenbogen AL, Fernandez HH, et al
    IPX203 vs Immediate-Release Carbidopa-Levodopa for the Treatment of Motor Fluctuations in Parkinson Disease: The RISE-PD Randomized Clinical Trial.
    JAMA Neurol. 2023 Aug 14:e232679. doi: 10.1001/jamaneurol.2023.2679.
    >> Share

  118. WOLF S, Mielke D, Barner C, Malinova V, et al
    Effectiveness of Lumbar Cerebrospinal Fluid Drain Among Patients With Aneurysmal Subarachnoid Hemorrhage: A Randomized Clinical Trial.
    JAMA Neurol. 2023;80:833-842.
    >> Share

    July 2023
  119. CHALOS V, Venema E, Mulder MJHL, Roozenbeek B, et al
    Development and Validation of a Postprocedural Model to Predict Outcome After Endovascular Treatment for Ischemic Stroke.
    JAMA Neurol. 2023 Jul 31:e232392. doi: 10.1001/jamaneurol.2023.2392.
    >> Share

  120. BHATIA KD, Chowdhury S, Andrews I, Goetti R, et al
    Association Between Thrombectomy and Functional Outcomes in Pediatric Patients With Acute Ischemic Stroke From Large Vessel Occlusion.
    JAMA Neurol. 2023 Jul 24:e232303. doi: 10.1001/jamaneurol.2023.2303.
    >> Share

  121. BALA F, Singh N, Buck B, Ademola A, et al
    Safety and Efficacy of Tenecteplase Compared With Alteplase in Patients With Large Vessel Occlusion Stroke: A Prespecified Secondary Analysis of the ACT Randomized Clinical Trial.
    JAMA Neurol. 2023 Jul 10:e232094. doi: 10.1001/jamaneurol.2023.2094.
    >> Share

  122. SCHAPER FLWVJ, Nordberg J, Cohen AL, Lin C, et al
    Mapping Lesion-Related Epilepsy to a Human Brain Network.
    JAMA Neurol. 2023 Jul 3:e231988. doi: 10.1001/jamaneurol.2023.1988.
    >> Share

    June 2023
  123. WANG A, Jia B, Zhang X, Huo X, et al
    Efficacy and Safety of Butylphthalide in Patients With Acute Ischemic Stroke: A Randomized Clinical Trial.
    JAMA Neurol. 2023 Jun 26:e231871. doi: 10.1001/jamaneurol.2023.1871.
    >> Share

  124. HERNANDEZ-JIMENEZ M, Abad-Santos F, Cotgreave I, Gallego J, et al
    Safety and Efficacy of ApTOLL in Patients With Ischemic Stroke Undergoing Endovascular Treatment: A Phase 1/2 Randomized Clinical Trial.
    JAMA Neurol. 2023 Jun 20:e231660. doi: 10.1001/jamaneurol.2023.1660.
    >> Share

  125. ANDRES W, Rothstein A, Elser H, Sloane KL, et al
    Trends in the Prevalence of Stroke Among Community-Dwelling Individuals in the US, 1999-2018.
    JAMA Neurol. 2023;80:646-648.
    >> Share

    May 2023
  126. WARACH SJ, Ranta A, Kim J, Song SS, et al
    Symptomatic Intracranial Hemorrhage With Tenecteplase vs Alteplase in Patients With Acute Ischemic Stroke: The Comparative Effectiveness of Routine Tenecteplase vs Alteplase in Acute Ischemic Stroke (CERTAIN) Collaboration.
    JAMA Neurol. 2023 May 30:e231449. doi: 10.1001/jamaneurol.2023.1449.
    >> Share

  127. WARDLAW JM, Woodhouse LJ, Mhlanga II, Oatey K, et al
    Isosorbide Mononitrate and Cilostazol Treatment in Patients With Symptomatic Cerebral Small Vessel Disease: The Lacunar Intervention Trial-2 (LACI-2) Randomized Clinical Trial.
    JAMA Neurol. 2023 May 24:e231526. doi: 10.1001/jamaneurol.2023.1526.
    >> Share

  128. VAN DER ENDE NAM, Roozenbeek B, Smagge LEM, Luijten SPR, et al
    Safety and Efficacy of Dual Thrombolytic Therapy With Mutant Prourokinase and Small Bolus Alteplase for Ischemic Stroke: A Randomized Clinical Trial.
    JAMA Neurol. 2023 May 22:e231262. doi: 10.1001/jamaneurol.2023.1262.
    >> Share

  129. HITTLE M, Culpepper WJ, Langer-Gould A, Marrie RA, et al
    Population-Based Estimates for the Prevalence of Multiple Sclerosis in the United States by Race, Ethnicity, Age, Sex, and Geographic Region.
    JAMA Neurol. 2023 May 15:e231135. doi: 10.1001/jamaneurol.2023.1135.
    >> Share

  130. KHOSHKHOO S, Wang Y, Chahine Y, Erson-Omay EZ, et al
    Contribution of Somatic Ras/Raf/Mitogen-Activated Protein Kinase Variants in the Hippocampus in Drug-Resistant Mesial Temporal Lobe Epilepsy.
    JAMA Neurol. 2023 May 1:e230473. doi: 10.1001/jamaneurol.2023.0473.
    >> Share

  131. CHATURVEDI S
    Transcarotid Artery Revascularization for Stroke Prevention-Multiple Elephants in the Room.
    JAMA Neurol. 2023;80:435-436.
    >> Share

  132. CHAKRABORTY AP, Mukherjee A, Biswas A
    Limb to Cranial Overflow Dystonia in a Patient After Stroke.
    JAMA Neurol. 2023;80:529.
    >> Share

    April 2023
  133. MCENTIRE CRS, Fletcher A, Toledano M, Epstein S, et al
    Characteristics of Progressive Multifocal Leukoencephalopathy Associated With Sarcoidosis Without Therapeutic Immune Suppression.
    JAMA Neurol. 2023 Apr 24:e230841. doi: 10.1001/jamaneurol.2023.0841.
    >> Share

  134. SINKA L, Abraira L, Imbach LL, Zieglgansberger D, et al
    Association of Mortality and Risk of Epilepsy With Type of Acute Symptomatic Seizure After Ischemic Stroke and an Updated Prognostic Model.
    JAMA Neurol. 2023 Apr 10:e230611. doi: 10.1001/jamaneurol.2023.0611.
    >> Share

  135. CHABANNE R, Geeraerts T, Begard M, Balanca B, et al
    Outcomes After Endovascular Therapy With Procedural Sedation vs General Anesthesia in Patients With Acute Ischemic Stroke: The AMETIS Randomized Clinical Trial.
    JAMA Neurol. 2023 Apr 3:e230413. doi: 10.1001/jamaneurol.2023.0413.
    >> Share

    March 2023
  136. TAI XY, Torzillo E, Lyall DM, Manohar S, et al
    Association of Dementia Risk With Focal Epilepsy and Modifiable Cardiovascular Risk Factors.
    JAMA Neurol. 2023 Mar 27:e230339. doi: 10.1001/jamaneurol.2023.0339.
    >> Share

  137. SENERS P, Yuen N, Mlynash M, Snyder SJ, et al
    Quantification of Penumbral Volume in Association With Time From Stroke Onset in Acute Ischemic Stroke With Large Vessel Occlusion.
    JAMA Neurol. 2023 Mar 20. doi: 10.1001/jamaneurol.2023.0265.
    >> Share

  138. HSU CY, Saver JL, Ovbiagele B, Wu YL, et al
    Association Between Magnitude of Differential Blood Pressure Reduction and Secondary Stroke Prevention: A Meta-analysis and Meta-Regression.
    JAMA Neurol. 2023 Mar 20. doi: 10.1001/jamaneurol.2023.0218.
    >> Share

  139. LIANG P, Cronenwett JL, Secemsky EA, Eldrup-Jorgensen J, et al
    Risk of Stroke, Death, and Myocardial Infarction Following Transcarotid Artery Revascularization vs Carotid Endarterectomy in Patients With Standard Surgical Risk.
    JAMA Neurol. 2023 Mar 20. doi: 10.1001/jamaneurol.2023.0285.
    >> Share

  140. ZEDDE M, Moratti C, Pascarella R
    Multimodal Neuroimaging of Intimal Flap in a Basilar Artery Dissection.
    JAMA Neurol. 2023 Mar 13. doi: 10.1001/jamaneurol.2023.0126.
    >> Share

  141. MISTRY EA
    Building Evidence on Safety of Thrombolysis for Patients Undergoing Direct Oral Anticoagulant Treatment.
    JAMA Neurol. 2023;80:231-232.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016